TARS
Tarsus Pharmaceuticals, Inc.Healthcare$70.12
◆ Neutral
Mkt Cap: $2.98B|Float: 32.3M|SI: 15.6%|DTC: 7.3
Data as of market close Apr 2, 2026
IV Rank
93
IV Pctl
78%
HV 20d
4187.0%
52W Range
$39-$85
ATR(14)
$3.36
Exp. Move
±7.8%
P/C Ratio
1.16
Earnings
Apr 30
GEX Negative
DEX Long
Net Call Premium
IV High
Exp. Move Wide
TARS Key Options Data
- IV Rank
- 93%
- Total GEX
- $-0.00B
- Total DEX
- $0.2M
- Max Pain
- $70.00
- Expected Move
- ±7.8%
- Put/Call OI
- 1.16
- Net Premium
- $0.1M
- Spot Price
- $70.12
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$5.50 | ±7.8% | $64.62 | $75.62 |
| 2026-05-15 | 43 | ±$7.00 | ±10.0% | $63.12 | $77.12 |
| 2026-07-17 | 106 | ±$17.85 | ±25.5% | $52.27 | $87.97 |
| 2026-10-16 | 197 | ±$8.95 | ±12.8% | $61.17 | $79.07 |
| 2026-12-18 | 260 | ±$31.55 | ±45.0% | $38.57 | $101.67 |
Explore TARS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.